Literature DB >> 15083264

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

M Isabel Colado1, Esther O'Shea, A Richard Green.   

Abstract

RATIONALE AND
OBJECTIVES: The majority of experimental and clinical studies on the pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) tend to focus on its action on 5-HT biochemistry and function. However, there is considerable evidence for MDMA having marked acute effects on dopamine release. Furthermore, while MDMA produces long-term effects on 5-HT neurones in most species examined, in mice its long-term effects appear to be restricted to the dopamine system. The objective of this review is to examine the actions of MDMA on dopamine biochemistry and function in mice, rats, guinea pigs, monkeys and humans. RESULTS AND DISCUSSION: MDMA appears to produce a major release of dopamine from its nerve endings in all species investigated. This release plays a significant role in the expression of many of the behaviours that occur, including behavioural changes, alterations of the mental state in humans and the potentially life-threatening hyperthermia that can occur. While MDMA appears to be a selective 5-HT neurotoxin in most species examined (rats, guinea pigs and primates), it is a selective dopamine neurotoxin in mice. Selectivity may be a consequence of what neurotoxic metabolites are produced (which may depend on dosing schedules), their selectivity for monoamine nerve endings, or the endogenous free radical trapping ability of specific nerve endings, or both. We suggest more focus be made on the actions of MDMA on dopamine neurochemistry and function to provide a better understanding of the acute and long-term consequences of using this popular recreational drug.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083264     DOI: 10.1007/s00213-004-1788-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  176 in total

1.  A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.

Authors:  M Shankaran; G A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

2.  In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.

Authors:  U Scheffel; Z Szabo; W B Mathews; P A Finley; R F Dannals; H T Ravert; K Szabo; J Yuan; G A Ricaurte
Journal:  Synapse       Date:  1998-06       Impact factor: 2.562

3.  L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.

Authors:  C J Schmidt; C K Black; V L Taylor
Journal:  Eur J Pharmacol       Date:  1991-10-02       Impact factor: 4.432

4.  Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.

Authors:  C A Heidbreder; A C Thompson; T S Shippenberg
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

5.  Restraint as a stressor in mice: against the dopaminergic neurotoxicity of D-MDMA, low body weight mitigates restraint-induced hypothermia and consequent neuroprotection.

Authors:  E A Johnson; D S Sharp; D B Miller
Journal:  Brain Res       Date:  2000-09-01       Impact factor: 3.252

Review 6.  Dopaminergic mechanisms in idiopathic and drug-induced psychoses.

Authors:  J A Lieberman; B J Kinon; A D Loebel
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

7.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

8.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

Authors:  U V Berger; X F Gu; E C Azmitia
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

9.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Authors:  D L Commins; G Vosmer; R M Virus; W L Woolverton; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

10.  Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.

Authors:  M Johnson; I Elayan; G R Hanson; R L Foltz; J W Gibb; H K Lim
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

View more
  43 in total

1.  Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.

Authors:  J Rouine; M E Kelly; C Jennings-Murphy; P Duffy; I Gorman; S Gormley; C M Kerskens; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2014-11-01       Impact factor: 4.530

2.  Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.

Authors:  Kevin Sean Murnane; Shane Alan Perrine; Brendan James Finton; Matthew Peter Galloway; Leonard Lee Howell; William Edward Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2011-10-13       Impact factor: 4.530

3.  Pathways between ecstasy initiation and other drug use.

Authors:  Silvia S Martins; Lilian A Ghandour; Howard D Chilcoat
Journal:  Addict Behav       Date:  2006-12-13       Impact factor: 3.913

4.  3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.

Authors:  Jessica A Able; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

5.  Initial deficit and recovery of function after MDMA preexposure in rats.

Authors:  K A Brennan; S Schenk
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

Review 6.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

7.  Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

Authors:  Devon L Graham; Nicole R Herring; Tori L Schaefer; Katherine D Holland; Charles V Vorhees; Michael T Williams
Journal:  Open Neuropsychopharmacol J       Date:  2012

8.  High-dose MDMA does not result in long-term changes in impulsivity in the rat.

Authors:  Kathryn S Saadat; J Martin Elliott; A Richard Green; Paula M Moran
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

9.  Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.

Authors:  I Peraile; E Torres; A Mayado; M Izco; A Lopez-Jimenez; J A Lopez-Moreno; M I Colado; E O'Shea
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

10.  Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.

Authors:  María Juliana Orejarena; Fernando Berrendero; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.